As part of its Clinical Trial Transparency initiative, the EMA
mandated a requirement for clinical trial sponsors to prepare a
summary of the results of every clinical trial written in language
understandable to lay persons (patients and others not in the
pharmaceutical industry). Lisa Chamberlain and James Barry
Drees at Trilogy Writing & Consulting discuss how important is the
requirement to prepare a summary of the results of every clinical
study.